New Simplera Sync™ Sensor for the MiniMed™ 780G System Secured FDA Approval, Advancing Insulin Delivery
On April 18, 2025, Medtronic plc, a global leader in healthcare technology, received FDA approval for its Simplera Sync™ sensor for integration with the MiniMed™ 780G system. This approval enhances the flexibility of Medtronic’s most advanced insulin delivery system, which now supports both the Guardian™ 4 and the newly approved Simplera Sync™ sensors. The Simplera Sync™ is a disposable, all-in-one continuous glucose monitoring (CGM) sensor that eliminates the need for fingersticks when used with SmartGuard™ technology and requires no overtape. Featuring a ...